QOL Medical
As of the edition of 20 October 2026, QOL Medical runs 4 drugs, 4 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 2 company names in this family.
- Evoke Pharma: acquired in 2025; successor QOL Medical, LLC
Drugs by status
| Status | Count |
|---|---|
| Marketed | 4 |
| Total | 4 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Metoclopramide | none listed | 3 |
| Cyanocobalamin | none listed | 0 |
| Sacrosidase | Ended 2010 (computed from the first US licence) | 0 |
| Ethanolamine oleate | none listed | 0 |
A route B row is one company at one target.